|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Royalty Pharma (NASDAQ: RPRX) through any online brokerage.
The latest price target for Royalty Pharma (NASDAQ: RPRX) was reported by UBS on November 9, 2020. The analyst firm set a price target for 51.00 expecting RPRX to rise to within 12 months (a possible 26.46% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Royalty Pharma (NASDAQ: RPRX) is $40.33 last updated Fri Jul 23 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
The next Royalty Pharma (RPRX) dividend date is projected to be 2021-08-19.
There is no upcoming split for Royalty Pharma.
Royalty Pharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.